Neuromodulation Market Set For Rapid Growth and Trend By 2026
Neuromodulation is an emerging field in the healthcare industry, offering a range of therapies for treating various neurological conditions. It involves the use of electrical or chemical stimulation to alter the activity of neurons in the brain or peripheral nervous system. This stimulation can be used to treat a variety of medical conditions, including chronic pain, spasticity, movement disorders, depression, epilepsy, and more. The global neuromodulation market is projected to reach USD 10.4 billion by 2027 from USD 6.0 billion in 2022, at a compound annual growth rate (CAGR) of 11.8% during the forecast period (2022-2027). This growth is attributed to factors such as the increasing prevalence of neurological conditions, the rising demand for minimally invasive treatment, and the growing awareness about the safety and efficacy of neuromodulation therapies. The neuromodulation market is segmented based on device type, application, end user, and geography. Based on device type, th...